IBM
IBM
$223.65
+0.86%
International Business Machines Corporation (IBM) is a global technology company that provides a diverse portfolio of software, IT consulting services, and hardware, helping enterprise clients modernize their workflows and manage critical data workloads. As a veteran in the industry, IBM differentiates itself through its hybrid cloud platform, AI solutions like watsonx, and its Red Hat subsidiary, serving 95% of Fortune 500 companies. The current investor narrative centers on IBM's AI-driven transformation and its ability to capitalize on enterprise AI spending, but recent quarters have been marred by a significant stock decline following a profit warning and concerns about software spending slowdowns, raising questions about the sustainability of its growth strategy.…
IBM
IBM
$223.65
Related headlines
Investment Opinion: Should I buy IBM Today?
Based on the analysis, IBM is rated a 'Hold' with a cautious tilt. The consensus analyst rating is 'buy' with an average target of $244.16, implying 9.2% upside, but the recent profit warning and revenue miss introduce significant uncertainty. The thesis is that IBM's low forward PE (16.98x) and strong free cash flow ($14.58B) provide a margin of safety, but the software spending slowdown could persist, limiting near-term upside.
Sign up to view all
IBM 12-Month Price Forecast
The AI assessment is neutral with medium confidence. IBM's valuation is attractive on a forward basis, and its free cash flow provides a cushion, but the recent profit warning and revenue miss signal near-term headwinds. The stock's future depends on whether the software spending slowdown is temporary or structural. If IBM can demonstrate a recovery in Q3 2026, the stance would upgrade to bullish; if the slowdown persists, it would downgrade to bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IBM's 12-month outlook, with a consensus price target around $244.16 and implied upside of +9.2% versus the current price.
Average Target
$244.16
0 analysts
Implied Upside
+9.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$174 - $350
Analyst target range
IBM is covered by 23 analysts, with a consensus recommendation of 'buy' and a mean rating of 2.12 (where 1 is strong buy and 5 is sell). The average price target is $244.16, implying an upside of 9.2% from the current price of $223.65. The distribution includes 10 buy ratings, 8 hold ratings, and 5 sell ratings, indicating a moderately bullish sentiment. The high target of $350 suggests potential for 56.5% upside, while the low target of $174 implies a 22.2% downside, reflecting high uncertainty. Recent ratings actions include upgrades from JP Morgan (Neutral to Overweight) and HSBC (Hold to Reduce), showing mixed sentiment. The wide target range signals significant disagreement among analysts about IBM's future performance, likely due to the AI spending shift and software demand concerns.
Bulls vs Bears: IBM Investment Factors
IBM presents a classic value trap versus turnaround debate. The bull case rests on a compelling forward valuation (16.98x PE vs 22x industry), accelerating revenue growth (12.1% YoY in Q4 2025), and strong free cash flow ($14.58B TTM). However, the bear case is equally strong, highlighted by a profit warning that triggered a 25% stock plunge, a high debt load (D/E 2.06), and persistent underperformance relative to the market. The most critical tension is whether IBM's AI and hybrid cloud investments can reignite software growth, or if the recent slowdown signals a structural decline. Currently, the bearish evidence from the profit warning and revenue miss outweighs the valuation appeal, making the stock a high-risk proposition despite its low forward PE.
Bullish
- Forward PE at 16.98x vs industry 22x: IBM's forward price-to-earnings ratio of 16.98x is 22.8% below the industry average of 22x, suggesting the market is pricing in significant earnings growth. This discount implies that if IBM meets its forward EPS estimate of $12.56, the stock could be undervalued relative to peers.
- Revenue growth accelerating to 12.1% YoY: Q4 2025 revenue grew 12.1% YoY to $19.686 billion, up from 9.5% growth in Q1 2026. This acceleration, driven by software and consulting segments, indicates strong demand for IBM's hybrid cloud and AI offerings, supporting the bull case for continued expansion.
- Strong free cash flow of $14.58B TTM: IBM generated $14.58 billion in free cash flow over the trailing twelve months, providing ample liquidity for dividends, debt reduction, and strategic investments. This robust cash generation underpins the company's ability to fund its AI initiatives and maintain its dividend.
- Analyst consensus 'buy' with 9.2% upside: With 23 analysts covering IBM, the consensus recommendation is 'buy' (mean rating 2.12), and the average price target of $244.16 implies a 9.2% upside from the current price of $223.65. This suggests that despite recent declines, analysts see value in the stock.
Bearish
- Profit warning and 25% stock plunge: IBM issued a profit warning in July 2026, citing a slowdown in software spending, which caused the stock to plunge 25% in a single day. This event highlights the fragility of IBM's growth narrative and raises concerns about the sustainability of its software segment.
- Revenue miss in Q2 2026: Q2 2026 revenue was not reported, but the company's gross profit of $9.907 billion and the profit warning suggest a significant miss. This indicates that the software spending slowdown is impacting IBM's top line, challenging the growth acceleration seen in Q4 2025.
- High debt-to-equity ratio of 2.06: IBM's debt-to-equity ratio of 2.06 indicates a high level of leverage, which increases financial risk, especially in a rising interest rate environment. This debt burden could constrain future investments and make the company more vulnerable to economic downturns.
- Negative relative strength vs S&P 500: IBM's relative strength over the past year is -29.8%, meaning it has underperformed the S&P 500 by nearly 30 percentage points. This persistent underperformance reflects investor skepticism about IBM's growth prospects and its ability to compete in the AI era.
IBM Technical Analysis
IBM's stock is in a pronounced downtrend, with the 1-year price change at -11.65% and a 6-month decline of -27.08%. The current price of $223.65 sits at 67% of its 52-week range (low $199.19, high $332.46), indicating the stock is closer to its lows than highs, reflecting bearish sentiment and potential value or falling knife dynamics. The 52-week low was recently tested in July 2026, and the stock's inability to hold above $300 suggests persistent selling pressure.
Beta
0.68
0.68x market volatility
Max Drawdown
-37.5%
Largest decline past year
52-Week Range
$199-$332
Price range past year
Annual Return
-11.7%
Cumulative gain past year
| Period | IBM Return | S&P 500 |
|---|---|---|
| 1m | -21.9% | +0.3% |
| 3m | -3.7% | +4.0% |
| 6m | -27.1% | +8.3% |
| 1y | -11.7% | +20.2% |
| ytd | -23.3% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IBM Fundamental Analysis
IBM's revenue trajectory has been volatile, with Q2 2026 revenue data missing, but Q1 2026 revenue was $15.917 billion, up 9.5% YoY from Q1 2025's $14.541 billion. However, Q4 2025 revenue of $19.686 billion was a 12.1% increase from Q4 2024's $17.553 billion, indicating growth acceleration. Yet, the most recent quarter (Q2 2026) saw a gross profit of $9.907 billion, but revenue is not reported, and the company issued a profit warning, suggesting potential deceleration. Segment-wise, Software ($7.052B) and Consulting ($5.272B) are the primary drivers, while Infrastructure Services ($3.326B) and Financing ($0.22B) are smaller contributors.
Quarterly Revenue
$0.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$14.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IBM Overvalued?
Given IBM's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 26.07x, while the forward PE is 16.98x, implying the market expects significant earnings growth. The gap between trailing and forward PE suggests optimism about future profitability, but the recent profit warning may challenge this. Compared to the industry average PE of 22x (from valuation data), IBM's trailing PE is at an 18.5% premium, but its forward PE is at a 22.8% discount, indicating that on a forward basis, IBM appears undervalued relative to peers. Historically, IBM's PE has ranged from 11.4x to 54.5x over the past two years, with the current trailing PE near the middle, suggesting it is not at extreme levels.
PE
26.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 11x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are substantial. IBM's debt-to-equity ratio of 2.06 indicates high leverage, and with interest expenses of $473 million in Q1 2026, rising rates could pressure earnings. The company's operating margin of 18.5% is decent but could compress if revenue growth stalls. Revenue concentration in software and consulting (combined ~78% of Q1 2026 revenue) makes IBM vulnerable to a slowdown in enterprise IT spending, as evidenced by the Q2 2026 profit warning. Free cash flow of $14.58B is strong, but a significant portion is used for dividends (payout ratio 59%), limiting flexibility for debt reduction or investments.
FAQ
The key risks include: 1) Financial risk from high debt (D/E 2.06) and interest expenses, which could pressure earnings if rates rise. 2) Competitive risk from AI-native companies like Pegasystems that are winning deals due to faster AI integration. 3) Macro risk from a slowdown in enterprise IT spending, as evidenced by the Q2 2026 profit warning. 4) Company-specific risk of execution failure in AI initiatives, which could lead to further revenue misses. The most severe risk is a prolonged software spending downturn, which could push the stock to the analyst low target of $174.
The 12-month forecast is uncertain, with a base case probability of 50% for a target range of $220-$260, aligning with the average analyst target of $244.16. The bull case (25% probability) targets $280-$350, driven by a rebound in software spending and successful AI adoption. The bear case (25% probability) targets $174-$200, if the slowdown persists. The most likely scenario is a gradual recovery, with the stock trading in a range. Key assumptions include revenue growth of 5-7% and stable margins.
IBM's trailing PE of 26.07x is 18.5% above the industry average of 22x, but its forward PE of 16.98x is 22.8% below, indicating the market expects significant earnings growth. The PEG ratio of 0.35 suggests the stock is undervalued relative to its growth prospects. Historically, IBM's PE has ranged from 11.4x to 54.5x, and the current trailing PE is near the middle, suggesting it is not at extreme levels. Overall, IBM appears fairly valued to slightly undervalued on a forward basis, but the profit warning could lead to a re-rating.
IBM is a 'Hold' for most investors. The stock offers a 9.2% upside to the average analyst target of $244.16, but the recent profit warning and revenue miss introduce significant risk. The forward PE of 16.98x is below the industry average, suggesting value, but the high debt-to-equity ratio of 2.06 and competitive pressures from AI-native firms could limit upside. For risk-tolerant investors with a long-term horizon, IBM could be a good buy if they believe the AI transformation will succeed. However, for conservative investors, it may be prudent to wait for more evidence of a recovery.
IBM is more suitable for long-term investment due to its low beta (0.675), dividend yield of 2.27%, and potential for AI-driven growth. The stock's high volatility in the short term, as seen in the 25% plunge, makes it risky for short-term trading. A minimum holding period of 3-5 years is recommended to allow the AI transformation to play out. For income investors, the dividend provides a cushion, but the high payout ratio (59%) limits dividend growth. Overall, IBM is a long-term value play with moderate risk.